HB-300
HOOKIPA Pharmaceuticals
['pcsm', 'prostate']
 s dr. biren saraiya &amp; colleagues present hb-300, a novel arenavirus-based cancer #immunotherapy in patients with metastatic castration-resistant #prostate cancer. at #asco23 #pcsm #ascodailynews 
Rutgers Cancer Institute of New Jersey is the state’s only NCI-designated Comprehensive Cancer Center and a leader in patient care and cancer research.